National Healthcare (NHC) Sr. VP receives 14,000-share stock option grant

Rhea-AI Filing Summary

National Healthcare Corp senior executive receives stock option grant. Sr. VP Patient Services Vicki L. Dodson was granted options to purchase 14,000 shares of National Healthcare Corp common stock on February 23, 2026, at an exercise price of $0.00 per share under the 2020 Omnibus Equity Incentive Plan.

According to the grant’s terms, these stock options vest in three equal installments: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. Following the grant, she directly holds multiple option positions and 10,289.5455 shares of common stock in her name.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Dodson Vicki L

Role Sr.VP Patient Srvcs

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	14,000	$0.00	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Shares of Common Stock held in my name	--	--	--

Holdings After Transaction: Option to Purchase Common Stock — 14,000 shares (Direct); Shares of Common Stock held in my name — 10,289.546 shares (Direct)

Footnotes (1)

1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dodson Vicki L

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr.VP Patient Srvcs

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Shares of Common Stock held in my name								10,289.5455	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	3,734		3,734	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	13,500		13,500	D
Option to Purchase Common Stock	$157.13	02/23/2026		A		14,000(1)		02/24/2027(2)	02/24/2031	Common Stock	14,000	$0	14,000	D

Explanation of Responses:

1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

2. These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.

	/s/ Vicki L Dodson	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NHC report for Vicki L. Dodson?

National Healthcare Corp reported that Sr. VP Patient Services Vicki L. Dodson received a grant of options to purchase 14,000 shares of common stock on February 23, 2026. The options were issued under the company’s 2020 Omnibus Equity Incentive Plan as an equity-based compensation award.

What are the vesting terms of Vicki Dodson’s new NHC stock options?

The 14,000 stock options granted to Vicki Dodson vest ratably over three years. One-third vests on February 23, 2027, another third on February 23, 2028, and the final third on February 23, 2029, aligning the award with multi‑year service and performance.

What exercise price applies to Vicki Dodson’s NHC stock option grant?

The stock options granted to Vicki Dodson carry an exercise price of $0.00 per share, according to the Form 4 data. This indicates they were awarded as a compensation grant rather than purchased in an open-market transaction or standard option exercise at a market-based price.

How many NHC options does Vicki Dodson hold after this grant?

After the February 23, 2026 grant, Vicki Dodson directly holds options including the newly awarded 14,000-share grant, plus other option positions showing post-transaction balances of 3,734, 8,000, and 13,500 options. These positions represent separate grants with differing remaining quantities outstanding.

How many NHC common shares does Vicki Dodson directly own?

Vicki Dodson directly owns 10,289.5455 shares of National Healthcare Corp common stock in her own name, as reported in the Form 4. This figure reflects her direct share ownership position, separate from any stock options or other derivative equity awards disclosed.